Comparative analysis of serum trace element levels in women with invasive cervical cancer in Lagos, Nigeria

Comparative analysis of serum trace element levels in women with invasive cervical cancer in Lagos, Nigeria

Kehinde Sharafadeen Okunade^1,&, Olayemi Olubunmi Dawodu², Omolola Salako³, Gbemisola Eniola Osanyin¹, Adeyemi Adebola Okunowo¹, Rose Ihuoma Anorlu¹

 

¹Department of Obstetrics & Gynaecology, College of Medicine, University of Lagos, Nigeria, ²Department of Anatomic and Molecular Pathology, College of Medicine, University of Lagos, Nigeria, ³Department of Radiation Oncology, Lagos University Teaching Hospital, Nigeria

 

 

^&Corresponding author
Kehinde Sharafadeen Okunade, Department of Obstetrics & Gynaecology, College of Medicine, University of Lagos, Nigeria

 

 

 

 

Cervical cancer is the second most common cancer among women in the developing countries and the seventh most common cancer in the developed countries [1]. Over 500,000 new cases are seen yearly [1] with over 80% of them being from the developing countries [1, 2]. Worldwide, it claims the lives of 300,000 women annually with over 80% coming from the developing countries [1]. It is the most common gynaecological cancer and a leading cause of cancer deaths among women in Nigeria [3]. Out of the estimated 14,550 women who are diagnosed with the disease in Nigeria annually, 9,659 will die from it [4]. Accumulation of free radicals has been implicated in the pathogenesis of many diseases [5]. Trace elements although present in minute quantities in human blood, play a vital role in many biochemical enzymatic reactions and have been examined critically as a potential key factor in various human diseases including cancers. They are known to play a pivotal role in the process of normal growth and differentiation of various tissues in animals and humans [6]. Their requirement for sustenance of tumour cell proliferation is hence considered to be of significant importance [7]. Hence their roles in the prevention of cervical cancer and other invasive cancers of humans are now subjects of discussions and intensive research interests [8-10]. Zinc is one such essential element that prevents the formation of free radicals. In addition to its role as an anti-oxidant, zinc is also known to participate in nearly 120 reactions taking place in a living organism [6].

 

More recently, studies have shown that this element may also play an important regulatory role in initiation of cell-mediated immunity [11]. Recent studies have demonstrated that Zinc deficiency seriously inhibited the development of lymphoid organs, impaired the progression of lymphocytes from the G0/G1 phase to the S phase and caused pathological injury in the lymphoid organs [12]. Significant changes have also been observed for serum copper concentration in various malignant conditions [13] and as a result serum copper concentration is considered as a non-specific marker for monitoring the progression of malignant disease [14]. The essential trace element, Selenium, is one of the major non-enzymatic endogenous antioxidants in human body. The interest of oncologists is now in its roles as a radioprotection of normal tissues, radio-sensitizer in malignant tumours, anti-oedematous effect, prognostic impact and its effects in primary and secondary cancer prevention [15]. Selenium is a constituent of the small group of selenocysteine-containing selenoproteins and elicits important structural and enzymatic functions [16]. It has been shown to possess cancer-preventive and cytoprotective activities in both animal models and humans. It is well established that Selenium has a key role in redox regulation and antioxidant function and hence in membrane integrity, energy metabolism and protection against DNA damage [17]. The serum levels of zinc, copper and selenium in invasive cervical cancer patients have been investigated by a good number of researchers both within and outside Nigeria, with variations in the reported findings [6, 17-19]. There are however, still limited data available to show the association between these trace elements and invasive cancer of the cervix among Nigerian women. This hospital based study was therefore aimed to evaluate the levels of these important trace elements in Nigerian women with invasive cervical cancer.

 

 

This was an analytical cross-sectional study carried out among women seen at the cytology and gynaecology out-patient clinics of the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria. LUTH is an over 1000 bedded teaching hospital located in the Central Lagos metropolis in South-West Nigeria. The hospital provides services to patients from the neighbouring South-Western states. It is the largest in the state and offers mainly clinical services among which include gynaecological oncology services. The gynaecology clinic is an-all female clinic with the cytology clinic being an off-shoot of it. In addition to receiving patients from the gynaecology clinic, the cytology clinic is the meeting point for all women from all other clinics of the hospital referred for routine cytological evaluation. The sample size (N) for the study was calculated using the statistical formula by Schlesselman [20]. Participants for the study were grouped as follows: 50 recently diagnosed patients with squamous cells carcinoma of the cervix and 100 control subjects who had no malignancy. Eligible subjects for the case group were women with biopsy proved cases of squamous cells carcinoma of the cervix; that had not undergone any treatment i.e. surgery, chemotherapy or radiotherapy; who did not suffer from any major illness in the past; who had not taken long course of any mineral supplement during the last six months. The control subjects were those who were not suffering from any cancerous lesions. The case and control subjects belonged to the same socio-economic status and same diet habits. Informed written consent was obtained from each participant upon explanation of the nature and purpose of the study. A structured interviewer-administered questionnaire was then used to collect relevant data. A volume of 5ml venous blood samples were obtained by venepuncture and collected in Ethylenediaminetetraacetic acid (EDTA) bottle. Standard precautions for trace element determination were taken and samples with signs of haemolysis discarded. Serum Zinc and Copper concentrations were estimated using direct atomic absorption spectrophotometer [21]. Selenium concentration was measured using the hydride generation method [22]. Serum was digested by a mixture of nitric and perchloric acid. After hydride generation and using a sodium borohydride method, the selenium concentration is then determined (AAS Model ECI 4141). All data were entered in the computer and analysed using SPSS version 22.0 statistical package for windows manufactured by IBM Corp, Armonk, NY, United States. Descriptive statistics were then computed for all continuous data and expressed as mean and standard deviation. The associations between any two groups of continuous variables were tested using the independent sample t-test. Statistical significance was defined as P<0.05.

 

Ethical approval: ethical approval for the study was obtained from the hospital's Health Research and Ethics committee prior to the commencement of the study and the ethical principles according to the Helsinki declaration were considered during the course of the research.

 

 

The demographic characteristics of the study participants are presented in Table 1 and there were no statistically significant differences between patients with cervical cancer and their control counterparts with regards to age (P=0.177), BMI (P=0.093), and total albumin levels (P=0.134). However there was a significant difference in the haemoglobin levels between the two groups of participants (P=0.042) The results as presented in Figure 1 showed the comparisons between the mean serum levels of trace elements in participants having squamous cells carcinoma and their cancer-free controls.

 

Zinc: the mean serum level of zinc was significantly lower in the cervical cancer group than the cancer-free control group (70.1 ± 11.7 µg/dL vs. 105.8 ± 16.5 µg/dL; P=0.003).

 

Copper: the mean level was higher in the cervical cancer patients but there was no statistically significant difference in the level in serum of patients as compared to its level in normal control group of individuals (86.6 ± 15.5 µg/dL vs. 82.8 ± 20.3 µg/dL; P=0.099).

 

Selenium: there was a significantly lower mean selenium levels in the cervical cancer patients compared to the control participants (101.3 ± 7.7 µg/L vs. 120.9 ± 18.3 µg/L; P=0.026).

 

 

In this study, we investigated the levels of three serum trace elements in patients with histologically diagnosed cervical cancer compared with cancer-free controls. Our study found a reduction in haemoglobin levels among participants with histologically diagnosed cervical cancer and this has been explained to occur as a result of iron deficiency and tumour bleeding in these patients [19, 23]. The findings from our present study indicated a strong association of low serum levels of Zinc and Selenium with invasive squamous cells carcinoma of the cervix. Previous studies, just like this current study, have also reported that serum Zinc concentrations were decreased in patients with ovarian, testicular, cervical, bladder and renal cancer [24-28]. Zinc plays an anti-carcinogenic role through structural stabilization of deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and ribosome. It has a protective effect against free-radical injury [29]. Our study just like some other epidemiologic studies revealed that a low selenium level in serum increase the risk of human cancers such as cancer of the stomach, oesophagus, colon, lung, prostate and breast [30]. It has been suggested that selenium protects cell by inhibiting free oxygen radical production. Moreover, an important antioxidant Vitamin E is transported by selenoproteins. Selenium has been shown to possess cancer-preventive and cytoprotective activities in animal models and humans [15, 31]. In our study, even though the mean serum concentration of Copper in the cancer patients was higher than in the controls, we did not find any statistically significant association. Copper plays a role in the production of haemoglobin, myelin, collagen and melanin as an essential nutrient [32] and studies have shown that normal immune function requires adequate Cu intake [7, 31, 32]. However, serum copper values are significantly elevated in many disease conditions such as chronic obstructive pulmonary disease (COPD), malignancies and psychosis [33]. The major limitations to this study were that it was hospital-based and thus the findings may not be generalizable to the public and also the study design will not allow us to conclude if Zinc and/or Selenium deficiencies actually preceded or occurred as a result of cervical cancer.

 

 

The study found significantly lower concentrations of zinc and selenium in cervical cancer patients. Zinc and selenium supplements may therefore result in reduced cervical cancer occurrence among high risk Nigerian women. However, future robust prospective studies are needed to determine if these trace element concentrations will impact clinical outcomes and to establish whether routine provision of these trace elements as supplements will result in improved cervical cancer treatment outcomes in Nigerian women.

 

 

The authors declare that competing interests.

 

 

All the authors contributed substantially to this study. Kehinde Sharafadeen Okunade, Olayemi Olubunmi Dawodu, Omolola Salako and Rose Ihuoma Anorlu contributed to the concepts and design of this study; Kehinde Sharafadeen Okunade, Olayemi Olubunmi Dawodu, Omolola Salako, Gbemisola Eniola Osanyin and Rose Ihuoma Anorlu contributed to the definition of intellectual content and literature search; Kehinde Sharafadeen Okunade, Olayemi Olubunmi Dawodu, Omolola Salako, Gbemisola Eniola Osanyin and Adeyemi Adebola Okunowo contributed to the data acquisition and collation. The final version of the manuscript draft was read and approved by all the authors

 

 

The authors wish to appreciate the efforts of the entire staff of the medical record department of the hospital and the staff of the Central research laboratory of the College of Medicine for all their logistical supports, without which this study would not have been possible. The work reported in this article was partly supported by the Oladele Akinla Trust Fund and the Fogarty International Center and National Institute of Mental Health of the National Institutes of Health (award no. D43TW010543). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Oladele Akinla Trust Fund and the National Institutes of Health.

 

 

Table 1: demographic characteristics of study participants

Figure 1: comparisons of mean serum levels of the trace elements in the cervical cancer patients and their controls

 

 

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2): 74-108. PubMed | Google Scholar


2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917. PubMed | Google Scholar


3. Thomas J, Ojemakinde O, Izebraye I. Current concepts in cervical carcinogenesis and new perspectives in prevention. Arch Ibadan Med. 2002; 3(1): 36-9. Google Scholar


4. WHO/ICO HPV information centre on HPV and cervical cancer (HPV information centre). Human papilloma viruss and related cancers in Nigeria. Summary report 2010.


5. Owoeye IOG, Ibrahim IA. Knowledge and attitude towards cervical cancer screening among female students and staff in a tertiary institution in the Niger Delta. Int J Med Biomed Res. 2013; 2(1): 48-56. Google Scholar


6. Okonkwo CA, Amegor FO, Gbolade JO. Relationship between Trace Elements and Major Gynaecological Malignancies. Asian Journal of Medical Sciences. 2013; 5(6): 124-127.


7. Gecit I, Kavak S, Demir H, Günes M, Pirinççi N, Çetin C et al. Serum Trace Element Levels in Patients with Bladder Cancer. Asian Pac J Cancer Prev. 2011; 12(12): 3409-13. PubMed | Google Scholar


8. Martin-Lagos F, Navarro-Alarcon M, Terres-Martos C, Lopez-G de la Serrana H, Lopez-Martinez MC. Serum copper and zinc concentrations in serum from patients with cancer and cardiovascular disease. The Science of the Total Environment. 1997; 204(1): 27-35. PubMed | Google Scholar


9. Goyal MM, Kalwar AK, Vyas RK, Bhati A. A study of serum zinc, selenium and copper levels in carcinoma of esophagus patients. Indian Journal of Clinical Biochemistry. 2006; 21(1): 208-210. PubMed | Google Scholar


10. Zuo XL, Chen JM, Zhou X, Li XZ, Mei GY. Levels of selenium, zinc, copper and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res. 2006; 114(1-3): 41-53. PubMed | Google Scholar


11. Rink L, Haase H. Zinc homeostasis and immunity. Trends Immunol. 2007; 28(1): 1-4. PubMed | Google Scholar


12. Cui H, Xi P, Junliang D, Debing V, Guang Y. Pathology of lymphoid organs in chickens fed a diet deficient in zinc. Avian Pathol. 2004; 33(5): 519-524. PubMed | Google Scholar


13. Cavallo F, Gerber M, Marubini E, Richardson S, Barbieri A, Costa A et al. Zinc and copper in breast cancer: a joint study in northern Italy and southern France. Cancer. 1991; 67(3): 738-745. PubMed | Google Scholar


14. Chakravarty PK, Ghosh A, Chowdhury JR. Plasma and erythrocyte copper level as an indicator of disease activity during malignancy. Cancer Lett. 1994; 84(2): 177-182. PubMed | Google Scholar


15. Micke O, Schomburg L, Buentzel J, Kisters K, Muecke R. Selenium in oncology: from chemistry to clinics. Molecules. 2009; 14(10): 3975-3988. PubMed | Google Scholar


16. Schomburg L, Koehrle J. Selenium: benefits and risks. MMW Fortschr Med. 2007; 149(8): 34-36. PubMed | Google Scholar


17. Naidu MS, Suryakar AN, Swami SC, Katkam RV, Kumbar KM. Oxidative stress and anti-oxidant status in cervical cancer patients. Indian J Clin Biochem. 2007; 22(2): 140-144. PubMed | Google Scholar


18. Wong WSF, Arumanayagam M, Chang MZA. Copper and zinc levels in patients with cervical neoplasia: clinical evaluation of the copper/zinc ratio. J Obstet Gynaecol. 1987; 8(1): 53-56. Google Scholar


19. Thompson FE, Patterson BH, Weinstein SJ, McAdams M, Spate VL, Hamman RF et al. Serum selenium and the risk of cervical cancer among women in the United States. Cancer Causes Control. 2002; 13(6): 517-26. PubMed | Google Scholar


20. Schlesselman JJ. Sample size requirements in cohort and case-control studies of disease. The American Journal of Epidemiology. 1974; 99(6): 381-384. PubMed | Google Scholar


21. Varian instruments AA at Work. AA-93, Jan 1990.


22. Varian instruments AA at Work. AA-82, Apr 1988.


23. Candelaria M, Cetina L, Dueñas-González A. Anemia in cervical cancer patients: implications for iron supplementation therapy. Med Oncol. 2005; 22(2): 161-8. PubMed


24. Zowczak M, Iskra M, Torlinski L, Cofta S. Analysis of serum copper and zinc concentrations in cancer patients. Biol Trace Elem Res. 2001; 82(1-3): 1-8. PubMed | Google Scholar


25. Pirincci N, Gecit I, Gunes M, Kaba M, Tanik S, Yuksel MB et al. Levels of serum trace elements in renal cell carcinoma cases. Asian Pac J Cancer Prev. 2013; 14(1): 499-502. PubMed | Google Scholar


26. Cunzhi H, Jiexian J, Xianwen Z, Jingang G, Shumin Z, Lili D. Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biol Trace Elem Res. 2003; 94(2): 113-22. PubMed | Google Scholar


27. Yaman M, Kaya G, Simsek M. Comparison of trace element concentrations in cancerous and noncancerous human endometrial and ovary tissues. Int J Gynecol Cancer. 2007; 17(1): 220-8. PubMed | Google Scholar


28. Kaba M, Pirinççi N, Yüksel MB, Geçit I, Günes M, Demir M et al. Serum Levels of Trace Elements in patients with Testicular Cancers. Int Braz J urol. 2015; 41(6): 1101-07. PubMed | Google Scholar


29. Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E. Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol. 2004; 14(3): 195-201. PubMed | Google Scholar


30. Miyamoto H, Araya Y, Ito M, Isobe H, Dosaka H, Shimizu T et al. Serum selenium and vitamin E concentration in families of lung cancer patients. Cancer. 1987; 60(5): 1159-62. PubMed | Google Scholar


31. Combs Jr GF. Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr. 2005; 135(2): 343-7. PubMed | Google Scholar


32. Sayir F, Kavak S, Meral I, Demir H, Cengiz N, Cobanoglu U. Effects of crush and axotomy on oxidative stress and some trace element levels in phrenic nerve of rats. Brain Res Bull. 2013; 92: 84-8. PubMed | Google Scholar


33. Sullivan JF, Blotcky AJ, Jetton MM, Hahn HK, Burch RE. Serum levels of selenium, calcium, copper, magnesium, magnise and zinc in various human diseases. J Nutr. 1979; 109(8): 1432-7. PubMed | Google Scholar